$3.7M Grant Will Fund Malignant Infantile Osteopetrosis Research 
rawpixel / Pixabay

$3.7M Grant Will Fund Malignant Infantile Osteopetrosis Research 

  In mid-November, 2020, Rocket Pharmaceuticals announced that the company received a $3.7M grant from the California Institute for Regenerative Medicine to study potential treatments for malignant infantile osteopetrosis. In…

Continue Reading $3.7M Grant Will Fund Malignant Infantile Osteopetrosis Research